Approval · Notice of Compliance 17096 · 2015

VIIBRYD: Notice of Compliance 17096

Issued July 16, 2015

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number: 17096
Date: July 16, 2015
Company: Forest Laboratories Canada IncMarkham, Ontario, Canada
Product type: Prescription Pharmaceutical
Submission: New Drug Submission (NDS)
Submission class: New Active Substance (NAS)
Therapeutic class: Antidepressant

Products in this notice

Brand	DIN	Status today
VIIBRYD	02443724	Marketed
VIIBRYD	02443732	Marketed
VIIBRYD	02443740	Marketed
VIIBRYD	02443759	Cancelled Post Market
VIIBRYD	02443767	Cancelled Pre Market

Medicinal ingredients

VILAZODONE HYDROCHLORIDE 10 MG per TAB
VILAZODONE HYDROCHLORIDE 20 MG per TAB
VILAZODONE HYDROCHLORIDE 40 MG per TAB